BACKGROUND: Resistin is a newly identified adipocytokine which has demonstrated links between obesity and insulin resistance in rodents. In humans, proinflammatory properties of resistin are superior to its insulin resistance-inducing effects. OBJECTIVES: To assess resistin expression in synovial tissues, serum and synovial fluid from patients with rheumatoid arthritis, osteoarthritis and spondylarthropathies (SpA), and to study its relationship with inflammatory status and rheumatoid arthritis disease activity. METHODS: Resistin expression and localisation in synovial tissue was determined by immunohistochemistry and confocal microscopy. Serum and synovial fluid resistin, leptin, interleukin (IL)1beta, IL6, IL8, tumour necrosis factor alpha, and monocyte chemoattractant protein-1 levels were measured. The clinical activity of patients with rheumatoid arthritis was assessed according to the 28 joint count Disease Activity Score (DAS28). RESULTS: Resistin was detected in the synovium in both rheumatoid arthritis and osteoarthritis. Staining in the sublining layer was more intensive in patients with rheumatoid arthritis compared with those with osteoarthritis. In rheumatoid arthritis, macrophages (CD68), B lymphocytes (CD20) and plasma cells (CD138) but not T lymphocytes (CD3) showed colocalisation with resistin. Synovial fluid resistin was higher in patients with rheumatoid arthritis than in those with SpA or osteoarthritis (both p<0.001). In patients with rheumatoid arthritis and SpA, serum resistin levels were higher than those with osteoarthritis (p<0.01). Increased serum resistin in patients with rheumatoid arthritis correlated with both CRP (r=0.53, p<0.02), and DAS28 (r=0.44, p<0.05), but not with selected (adipo) cytokines. CONCLUSION: The upregulated resistin at local sites of inflammation and the link between serum resistin, inflammation and disease activity suggest a role for resistin in the pathogenesis of rheumatoid arthritis.

Institute of Rheumatology 1st Medical Faculty Charles University Na Slupi 4 12850 Prague 2 Czech Republic and University Hospital Giessen Department of Internal Medicine and Rheumatology Germany

Zobrazit více v PubMed

Steppan C M, Brown E J, Wright C M.et al A family of tissue‐specific resistin‐like molecules. Proc Natl Acad Sci USA 200198502–506. PubMed PMC

Steppan C M, Bailey S T, Bhat S.et al The hormone resistin links obesity to diabetes. Nature 2001409307–312. PubMed

Nogueiras R, Gallego R, Gualillo O.et al Resistin is expressed in different rat tissues and is regulated in a tissue‐and gender‐specific manner. FEBS Lett 200354821–27. PubMed

Savage D B, Sewter C P, Klenk E S.et al Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator‐activated receptor‐gamma action in humans. Diabetes 2001502199–2202. PubMed

Degawa‐Yamauchi M, Bovenkerk J E, Juliar B E.et al Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003885452–5455. PubMed

McTernan P G, Fisher F M, Valsamakis G.et al Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003886098–6106. PubMed

Lee J H, Chan J L, Yiannakouris N.et al Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross‐sectional and interventional studies in normal, insulin‐resistant, and diabetic subjects. J Clin Endocrinol Metab 2003884848–4856. PubMed

Zwerina J, Redlich K, Schett G, Smolen J S. Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann N Y Acad Sci 20051051716–729. PubMed

Kaser S, Kaser A, Sandhofer A, Ebenbichler C F, Tilg H, Patsch J R. Resistin messenger‐RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003309286–290. PubMed

Reilly M P, Lehrke M, Wolfe M L, Rohatgi A, Lazar M A, Rader D J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005111932–939. PubMed

Schäffler A, Ehling A, Neumann E.et al Adipocytokines in synovial fluid. JAMA 20032901709–1710. PubMed

Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 20051745789–5795. PubMed

Arnett F C, Edworthy S M, Bloch D A.et al The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 198831315–324. PubMed

Prevoo M L, van't Hof M A, Kuper H H, van Leeuwen M A, van de Putte L B, van Riel P L. Modified disease activity scores that include twenty‐eight‐joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 19953844–48. PubMed

Minn A H, Patterson N B, Pack S.et al Resistin is expressed in pancreatic islets. Biochem Biophys Res Commun 2003310641–645. PubMed

Haluzík M, Colombo C, Gavrilova O.et al Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 20041453258–3264. PubMed

Jung H S, Park K H, Cho Y M.et al Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 20066976–85. PubMed

Anderlova K, Kremen J, Dolezalova R.et al The influence of very‐low‐calorie‐diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol Res 200655277–283. PubMed

Harle P, Sarzi‐Puttini P, Cutolo M, Straub R H. No change of serum levels of leptin and adiponectin during anti‐tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 200665970–971. PubMed PMC

Housova J, Wilczek H, Haluzik M M, Kremen J, Krizova J, Haluzik M. Adipocyte‐derived hormones in heroin addicts: the influence of methadone maintenance treatment. Physiol Res 20055473–78. PubMed

Banerjee R R, Rangwala S M, Shapiro J S.et al Regulation of fasted blood glucose by resistin. Science 20043031195–1198. PubMed

Otero M, Lago R, Gomez R.et al Changes in fat‐derived hormones plasma concentrations: adiponectin, leptin, resistin, and visfatin in rheumatoid arthritis subjects. Ann Rheum Dis 2006651198–1201. PubMed PMC

Stefan N, Haring H U, Stumvoll M. Regulation of synovial adipocytokines. JAMA 2004291694–695. PubMed

Schäffler A, Büchler C, Müller‐Ladner U.et al Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 200436702–707. PubMed

Brown R, Wiesner G, Ur E, Wilkinson M. Pituitary resistin gene expression is upregulated in vitro and in vivo by dexamethasone but is unaffected by rosiglitazone. Neuroendocrinology 20058141–44. PubMed

Smeets T J, Barg E C, Kraan M C, Smith M D, Breedveld F C, Tak P P. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis 200362635–638. PubMed PMC

Ehling A, Schäffler A, Tarner I H.et al The potential of adiponectin in driving arthritis. J Immunol 20061764468–4478. PubMed

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis

The role of resistin in inflammatory myopathies

Resistin in idiopathic inflammatory myopathies

No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitis